Showing results (1621-1630 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningiomaJulia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
Neuro-Oncology|January 31, 2016
Methylation profiling of choroid plexus tumors reveals 3 clinically distinct subgroupsChristian Thomas, Martin Sill, Vincent Ruland, et al.
Neuro-Oncology|January 13, 2016
Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapiesMichael C Frühwald, Jaclyn A Biegel, Franck Bourdeaut, et al.
Neuro-Oncology|December 19, 2015
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrierKaijun Di, G Kenneth Lloyd, Vivek Abraham, et al.
Neuro-Oncology|December 20, 2015
Predicting outcome of epilepsy after meningioma resectionHans-Georg Wirsching, Corinne Morel, Corinne Gmür, et al.
Neuro-Oncology|December 22, 2015
A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiationVaios Hatzoglou, T Jonathan Yang, Antonio Omuro, et al.
Neuro-Oncology|May 15, 2016
The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastomaF Bernard-Arnoux, M Lamure, F Ducray, et al.
Neuro-Oncology|March 30, 2016
Biology and management of ependymomasJing Wu, Terri S Armstrong, Mark R Gilbert
Neuro-Oncology|February 12, 2016
68Gallium-DOTATATE PET in meningioma: A reliable predictor of tumor growth rate?Michael Sommerauer, Jan-Karl Burkhardt, Karl Frontzek, et al.
Neuro-Oncology|March 18, 2016
Whole-brain spectroscopic MRI biomarkers identify infiltrating margins in glioblastoma patientsJames S Cordova, Hui-Kuo G Shu, Zhongxing Liang, et al.
Pageof 316